arrow
返回
J

Jia-Lin Lee

University of Ulsan College of Medicine

24H指数
107论文数
2.6K被引数
收录论文 46
发表时间
Novel pembrolizumab-based treatments as first-line therapy in advanced clear cell renal cell carcinoma: Substudy 03A of the open-label, umbrella platform, phase I/II KEYMAKER-U03 trial新型基于pembrolizumab的治疗方案作为晚期透明细胞肾细胞癌的一线疗法:开放标签、伞形平台、I/II期KEYMAKER-U03试验的子研究03A
err2025-10-18
err0
PREAI
errC. Suarez; C. Rojas; S.J. Shin; P.Yanez Weber; L. Albiges; R. Motzer; H. Hammers; A. Peer; J-L. Lee; W.H. Miller; T. Waddell; V. Neiman; D. Keizman; A.Zwenger Kloster; A. Weickhardt; R. Dziadziuszko; L. Suttner; M. Sharma; J.E. Burgents; T. Powles
err分享
err收藏
Patient characteristics and guideline directed medical therapy review of Hospital Sungai Buloh Heart Failure Registry 2023-2024
err2024-12-01
err0
PREAI
errLoh, L. C. W.; Lee, J. L.; Lim, E. L. S.; Sia, H. P.; Chong, P. F.; Abdullah, E. L.; Sothivadivel, S.; Saleh, N. M.
err分享
err收藏
Guideline-directed medical therapy in HFrEF: Are we doing enough?
err2024-12-01
err0
PREAI
errSia, H. P.; Chong, P. F.; Lim, E. L. S.; Loh, L. C. W.; Lee, J. L.; Abdullah, E. L.; Sothivadivel, S.
err分享
err收藏
Belzutifan versus everolimus for previously treated advanced clear cell renal cell carcinoma (ccRCC): Updated follow-up of the East Asian subgroup of the randomized phase III LITESPARK-005 trialBelzutifan与everolimus对比用于既往治疗过的晚期透明细胞肾细胞癌(ccRCC):随机III期LITESPARK-005试验东亚亚组的更新随访
err2024-12-01
err0
PREAI
errLee, J-L.; Park, S. H.; Kato, T.; Saika, T.; Masumori, N.; Oya, M.; Nishimoto, K.; Fujimoto, H.; Eto, M.; Kishida, T.; Lee, H. J.; Su, Y-L.; Miura, Y.; Matsubara, N.; Kitamura, H.; Cheng, A. C. K.; Xing, A.; Perini, R.; Vickery, D.; Rini, B. I.
err分享
err收藏
Xaluritamig, a STEAP1 x CD3 XmAb 2+1 immune therapy, in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Initial results from dose expansion cohorts in a phase I studyXaluritamig,一种STEAP1 x CD3 XmAb 2+1免疫疗法,在转移性去势抵抗性前列腺癌(mCRPC)患者(pts)中的初步研究结果:来自一项I期研究剂量扩展队列的数据
err2024-09-01
err0
PREAI
errKelly, W. K.; Appleman, L. J.; Lin, C-C.; Armstrong, A. J.; Fischer, S. C.; Pook, D. W.; Perez Gracia, J. L.; Lee, J. L.; Berthold, D. R.; Ward, P. J.; Castellano Gauna, D. E.; Horvath, L. G.; Kim, M.; Matsubara, N.; Sumey, C.; Shabooti, M.; Yang, Z.; Connarn, J.; Stieglmaier, J.; Danila, D. C.
err分享
err收藏
Circulating tumour cell (CTC) enumeration and overall survival (OS) in men with metastatic castration-resistant prostate cancer (mCRPC) treated with xaluritamig循环肿瘤细胞(CTC)计数和总生存期(OS)在用xaluritamig治疗的转移性去势抵抗性前列腺癌(mCRPC)男性患者中的情况
err2024-09-01
err0
PREAI
errArmstrong, A. J.; Appleman, L. J.; Danila, D. C.; Lin, C-C.; Lee, J. L.; Matsubara, N.; Ward, P. J.; Pook, D. W.; Kim, M.; Dorff, T. B.; Fischer, S. C.; Lin, Y-C.; Horvath, L. G.; Sumey, C.; Yang, Z.; Decato, B. E.; Englert, J. M.; Smith, K. M.; Lolkema, M.; Kelly, W. K.
err分享
err收藏
Interim results from a phase I study of AMG 509 (xaluritamig), a STEAP1 x CD3 XmAb 2+1 immune therapy in patients with metastatic castration-resistant prostate cancer (mCRPC)
err2023-11-01
err0
PREAI
errKelly, W. K.; Danila, D. C.; Lin, C-C.; Lee, J-L.; Matsubara, N.; Ward, P. J.; Armstrong, A. J.; Pook, D. W.; Kim, M.; Dorff, T.; Fischer, S.; Lin, Y-C.; Horvath, L. G.; Sumey, C.; Yang, Z.; Jurida, G.; Connarn, J.; Penny, H.; Stieglmaier, J.; Appleman, L. J.
err分享
err收藏
Tumor response by baseline metastases in patients (pts) with renal cell carcinoma (RCC) treated with lenvatinib (L) plus pembrolizumab (P) vs sunitinib (S): Post hoc analysis of the CLEAR trial
err2023-10-01
err1
errOAAI
errGruenwald, V.; Mckay, R. R.; Buchler, T.; Eto, M.; Park, S. H.; Takagi, T.; Zanetta, S.; Keizman, D.; Suarez Rodriguez, C.; Negrier, S.; Lee, J-L.; Santini, D.; Bedke, J.; Staehler, M.; Kollmannsberger, C. K.; Choueiri, T. K.; Motzer, R. J.; Burgents, J.; Okpara, C. E.; Powles, T. B.
err分享
err收藏
An open-label, multicenter, phase I/II study of GI-101, CD80-IgG4 Fc-IL2v, in advanced solid tumors (Part A of GII-101-P101; KEYNOTE-B59)
err2023-10-01
err0
errOAAI
errCho, B. C.; Lee, J-L.; Shim, B.; Shin, S. J.; Lee, H. J.; Lee, J-Y.; Powderly, J.; Lee, S.; Yun, N.; Ham, M.; Lee, K. E.; Lee, W. Y.; Kang, H.; Jang, M. H.
err分享
err收藏
Interim results from a phase I study of AMG 509 (xaluritamig), a STEAP1 x CD3 XmAb 2+1 immune therapy, in patients with metastatic castration-resistant prostate cancer (mCRPC)
err2023-10-01
err2
PREAI
errKelly, W.; Danila, D.; Lin, C-C.; Lee, J-L.; Matsubara, N.; Ward, P.; Armstrong, A. J.; Pook, D.; Kim, M.; Dorff, T.; Fischer, S.; Lin, Y-C.; Horvath, L. G.; Sumey, C.; Yang, Z.; Jurida, G.; Connarn, J.; Penny, H.; Stieglmaier, J.; Appleman, L. J.
err分享
err收藏
CD44 engagement promotes matrix-derived survival through the CD44-Src-integrin axis in lipid rafts
err2023-03-27
err101
errOAAI
errLee, Jia-Lin; Wang, Mei-Jung; Sudhir, Putty-Reddy; Chen, Jeou-Yuan
err分享
err收藏
SH2B1β Interacts with STAT3 and Enhances Fibroblast Growth Factor 1-Induced Gene Expression during Neuronal Differentiation
err2023-03-20
err16
errOAAI
errChang, Yu-Jung; Chen, Kuan-Wei; Chen, Ching-Jen; Lin, Ming-Hsing; Sun, Yuh-Ju; Lee, Jia-Lin; Chiu, Ing-Ming; Chen, Linyi
err分享
err收藏
Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up
err2023-03-01
err43
errOAAI
errBalar, A. V.; Castellano, D. E.; Grivas, P.; Vaughn, D. J.; Powles, T.; Vuky, J.; Fradet, Y.; Lee, J. -L.; Fong, L.; Vogelzang, N. J.; Climent, M. A.; Necchi, A.; Petrylak, D. P.; Plimack, E. R.; Xu, J. Z.; Imai, K.; Moreno, B. H.; Bellmunt, J.; de Wit, R.; O'Donnell, P. H.
err分享
err收藏
Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC): Longer-term follow-up from the Asian subgroup of the JAVELIN Bladder 100 trial
err2022-11-01
err0
errOAAI
errEto, M.; Desai, C. J.; Park, S. H.; Tsuchiya, N.; Su, P. J.; Chan, T. W.; Gurney, H. P.; Gao, S.; Wang, J.; Sandner, R.; di Pietro, A.; Lee, J-L.
err分享
err收藏
Efficacy and safety of pembrolizumab (pembro) monotherapy in East Asian patients (pts) with urothelial carcinoma (UC) in KEYNOTE-045 or KEYNOTE-052
err2022-11-01
err0
errOAAI
errLee, J-L.; Keam, B.; Kanesvaran, R.; Yamamoto, Y.; Su, W-P.; Chiang, P-H.; Lin, C-C.; Sassa, N.; Nishimura, K.; Fujimoto, K.; Chang, P. M-H.; Kim, M.; Fukasawa, S.; Yokoyama, M.; Enokida, H.; Xu, J.; Moreno, B. Homet; Imai, K.; Nishiyama, H.; Rha, S. Y.
err分享
err收藏
4-factor model to predict response and survival benefit with durvalumab (D) in previously treated metastatic urinary tract carcinoma (mUTC)
err2022-09-01
err0
errOAAI
errSonpavde, G. P.; Sternberg, C. N.; Lee, J-L.; Emeribe, U.; Oh, S. M.; De Lima, A. R. Dantas; Hotte, S. J.
err分享
err收藏
Impact of prior chemotherapy (Chemo) on pembrolizumab (Pembro) response in urothelial cancer (UC): Exploratory analysis of the phase III KEYNOTE-045 study
err2022-09-01
err0
errOAAI
errDe Wit, R.; Vaughn, D. J.; Fradet, Y.; Fong, L.; Vogelzang, N. J.; Climent Duran, M. A.; Necchi, A.; Petrylak, D. P.; Gerritsen, W. R.; Gurney, H. P.; Quinn, D. I.; Culine, S.; Sternberg, C. N.; Bajorin, D. F.; Choueiri, T. K.; Xu, J.; Imai, K.; Moreno, B. Homet; Bellmunt, J.; Lee, J-L.
err分享
err收藏
Characterization of patients with metastatic renal cell carcinoma achieving complete response to first-line therapies: Results from the international metastatic renal cell carcinoma database consortium (IMDC)
err2022-09-01
err1
errOAAI
errTakemura, K.; Navani, V.; Ernst, M. S.; Wells, J. C.; Choueiri, T. K.; Meza, L.; Pal, S. K.; Lee, J-L.; Li, H.; Agarwal, N.; Alva, A. S.; Hansen, A. R.; Basappa, N. S.; Szabados, B. E.; Powles, T. B.; Tran, B.; Hocking, C. M.; Beuselinck, B.; Yuasa, T.; Heng, D. Y. C.
err分享
err收藏
Tachypacing-induced CREB/CD44 signaling contributes to the suppression of L-type calcium channel expression and the development of atrial remodeling
err2021-10-01
err6
PREAI
errChang, Shang-Hung; Chan, Yi-Hsin; Chen, Wei-Jan; Chang, Gwo-Jyh; Lee, Jia-Lin; Yeh, Yung-Hsin
err分享
err收藏
Pembrolizumab (pembro) monotherapy as first-line therapy in advanced clear cell renal cell carcinoma (ccRCC): Results after a minimum of 41 months of follow-up from KEYNOTE-427 cohort A
err2021-09-01
err0
errOAAI
errMcDermott, D. F.; Lee, J-L.; Bjarnason, G. A.; Larkin, J.; Gafanov, R.; Kochenderfer, M. D.; Jensen, N. V.; Donskov, F.; Malik, J.; Poprach, A.; Tykodi, S. S.; Alonso-Gordoa, T.; Cho, D. C.; Geertsen, P. F.; Climent Duran, M. A.; Di Simone, C.; Liu, H.; Burgents, J.; Rodriguez-Lopez, K.; Atkins, M. B.
err分享
err收藏